Ketamine versus propofol for procedural sedation in pediatric pulsed dye laser therapy: a prospective randomized trial - Scorecard - MDSpire

Ketamine versus propofol for procedural sedation in pediatric pulsed dye laser therapy: a prospective randomized trial

  • By

  • Marija Stevic

  • Nina Ristic

  • Ivana Budic

  • Branislav Trifunovic

  • Vesna Marjanovic

  • Suzana Bojic

  • Dejan Zivorad Marković

  • Marija Jovanovski Srceva

  • Dragan Nenadic

  • Ana Vlajkovic Ivanovic

  • Lazar Milic

  • Dejan Nikolic

  • April 30, 2026

  • 0 min

Share

Clinical Scorecard: Comparison of Ketamine and Propofol for Sedation During Pediatric Pulsed Dye Laser Treatment: A Prospective Randomized Study

At a Glance

CategoryDetail
ConditionPort-wine stains (PWS)
Key MechanismsAnalgosedation using propofol or ketamine
Target PopulationChildren aged 1–18 years (ASA I–II)
Care SettingOutpatient procedures

Key Highlights

  • Respiratory depression was significantly higher in the propofol group (19.5%) compared to the ketamine group (2.6%).
  • Ketamine was associated with higher rates of hypertension, tachycardia, and psychomimetic effects.
  • Propofol led to more hypotension and longer recovery times compared to ketamine.
  • Sedation depth was comparable between both agents.
  • Procedural duration ≥13.5 min predicted respiratory depression in the propofol group.

Guideline-Based Recommendations

Diagnosis

  • Assess the need for analgosedation in pediatric patients undergoing PDL therapy.

Management

  • Consider ketamine for better respiratory stability, especially in longer procedures.

Monitoring & Follow-up

  • Standardized monitoring including ECG, blood pressure, pulse oximetry, and end-tidal CO₂ is essential.

Risks

  • Be aware of the higher risk of respiratory depression with propofol and other adverse effects with ketamine.

Patient & Prescribing Data

Children aged 1–18 years undergoing PDL therapy for PWS.

Individualize anesthetic selection based on procedural duration and patient risk factors.

Clinical Best Practices

  • Utilize standardized monitoring during sedation.
  • Evaluate the patient's ASA status before selecting sedative agents.
  • Educate caregivers about potential side effects of both propofol and ketamine.

References

Original Source(s)

Related Content